R1 RCM Inc. (NASDAQ:RCM) Q1 2022 Earnings Conference Call May 9, 2022 8:00 AM ET

Company Participants

Atif Rahim - Head, Investor Relations

Joe Flanagan - President & Chief Executive Officer

Rachel Wilson - Executive Vice President, Chief Executive Officer & Treasurer

Conference Call Participants

Stephanie Davis - SVB Securities

Sean Dodge - RBC Capital Markets

Vikram Kesavabhotla - Baird

Glen Santangelo - Jefferies

Charles Rhyee - Cowen

Jack Wallace - Guggenheim Partners

George Hill - Deutsche Bank

Operator

Good morning. My name is Chris and I'll be your conference operator today. At this time, I'd like to welcome everyone to the R1 RCM Q1 2022 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks there will be a question-and-answer session [Operator Instructions] Thank you.

Atif Rahim Head of Investor Relations. You may begin.

Atif Rahim

Good morning, everyone and welcome to the call. Certain statements made during this call may be considered forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In particular any statements about our future growth, plans and performance including statements about the proposed acquisition of Cloudmed and its expected benefits our strategic and cost-saving initiatives, our liquidity position, our growth opportunities and our future financial performance are forward-looking statements. These statements are often identified by the use of words such as anticipate, believe, estimate, expect, intend, design, may, plan, project, work, and similar expressions or variations. Investors are cautioned not to place undue reliance on such forward-looking statements.

All forward-looking statements made on today's call involve risks and uncertainties. While we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent as required by applicable laws. Our actual results and outcomes could differ materially from those included in these forward-looking statements as a result of various factors, including but not limited to the potential acquisition of Cloudmed, which may not be completed on our anticipated time line or at all, our growth strategy, the impact of the COVID-19 pandemic and factors discussed under the heading Risk Factors in our most recent annual report on Form 10-K, our latest quarterly report on Form 10-Q and our proxy statement and prospectus for our upcoming annual meeting.

We will also be referencing non-GAAP metrics on this call. For a reconciliation of the non-GAAP amounts mentioned to the equivalent GAAP amounts, please refer to our press release. Information related to Cloudmed is based on data available to us and is subject to change.